Enzymatic assays using umbelliferone substrates with cyclodextrins in droplets in oil

• US 8,093,062 B2
• Filed: 01/25/2011
• Issued: 01/10/2012
• Est. Priority Date: 03/22/2007
• Status: Active Grant

• Current Assignee: Advanced Liquid Logic, Inc. (Illumina Incorporated)
• Original Assignee: Advanced Liquid Logic, Inc. (Illumina Incorporated)
• Inventors: Winger, Theodore
• Primary Examiner(s): Warden, Jill
• Assistant Examiner(s): COLE, MONIQUE T
• Application Number:
  US13/012,831
• Publication Number:
  US 20110118132A1
• Time in Patent Office: 350 Days
• Field of Search: 436/86
• US Class Current: 436/86
• CPC Class Codes: C12Q 1/00 Measuring or testing processes involving enzymes, nucleic acids or microorganisms measuring or testing apparatus with condition measuring or sensing means, e.g. colony counters, C12M1/34; Compositions therefor; Processes of preparing such compositions

Abstract

The invention is directed to droplet actuator devices and assay methods. The method may include, among other things, a method of conducting enzymatic assays using umbelliferone substrates with cyclodextrins in droplets in oil, the method including incubating a droplet in oil, the droplet preferably comprising an umbelliferone substrate, a sample, and a cyclodextrin compound. The methods may further include a method of substantially eliminating cross-contamination between droplets in enzymatic containing substrate-based bioassays. The method may include immobilization of the enzymatic substrate including forming an inclusion complex with the substrate for stabilizing the substrate within an aqueous environment, wherein the inclusion complex may be formed using cyclodextrins. In yet another embodiment, the invention may provide a method of enhancing hydrolysis of enzymatic substrates. The methods may further include a method of forming an inclusion complex with the substrate for stabilizing the substrate within an aqueous environment, wherein the substrate may be a 4-MU- or HMU containing substrate. The inclusion complex may be formed using cyclodextrin.

Claims

1. A method of conducting an assay, the method comprising (a) incubating a droplet in oil, the droplet comprising an umbelliferone substrate, a sample potentially comprising an enzyme which cleaves the umbelliferone substrate, and a cyclodextrin compound;

and (b) detecting a signal emitted from the droplet.

2. The method of claim 1 wherein the cyclodextrin compound is selected from the group consisting of α

-cyclodextrins, β

-cyclodextrins, and γ

-cyclodextrins, and analogs and derivatives of the foregoing.

3. The method of claim 1 wherein the umbilliferone substrate is selected from the group consisting of alkylumbelliferyl-α

-L-iduronides, 4-methylumbelliferyl-α

-L-iduronide, 4-methylumbelliferyl-α

-L-iduronide-2-sulfate, 4-methylumbelliferyl-α

-L-idopyranosiduronic acid, 4-methylumbelliferyl-α

-L-fucoside, 4-methylumbelliferyl-α

-L-mannoside, 4-methylumbelliferyl-β

-D-mannoside, 4-methylumbelliferyl β

-D-N-acetylglucosaminide, 4-methylumbelliferyl β

-D-N-acetylglucosaminide sulfate, alkylumbelliferyl-β

-D-glycosides, methylumbelliferyl-β

-D-glycosides, 4-methylumbelliferyl-α

-D-galactoside, 4-methylumbelliferyl-β

-D-galactoside, 4-methylumbelliferyl-β

-D-glucouronic acid, phenolphthalein-β

-D-glucuronic acid, ethylumbelliferyl-β

-D-glycosides, multifluoroethylumbelliferyl-β

-D-glycosides, pentafluoroethylumbelliferyl-β

-D-glycosides, pentafluoroethylumbelliferyl-β

-D-glucoside, umbelliferylchiotriosides, 4-alkyumbelliferylchiotrioside, 4-methylumbelliferylchiotrioside, 4-methylumbelliferyl-β

-galactose, 4-alkyumbeliferrone phosphates, 4-methylumbeliferrone phosphate, 6-alkanoylamido-4-methylumbelliferones, substrates comprising a 4-methyllumbelliferyl group, 6-hexadecanoylamido-4-methylumbelliferone, 4-methyllumbelliferyl-β

-D-glucosaminide, 4-methylumbelliferyl-α

-neuraminic acid, 4-methylumbelliferyl-α

-D-N-acetylgalactosaminide, and their functional analogs and derivatives.

4. The method of claim 1 wherein the incubating is performed within droplets controlled by a droplet actuator.

5. The method of claim 4 wherein the droplets are controlled using electrode mediated droplet operations.

6. The method of claim 4 wherein the droplets are controlled using electrowetting mediated droplet operations.

7. The method of claim 4 wherein the droplets are controlled using dielectrophoresis mediated droplet operations.